Hyponatraemia in patients on immune checkpoint inhibitors.
作者信息
Paschou Stavroula A, Kassi Evanthia, Psaltopoulou Theodora
机构信息
Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, 80 Vasilisis Sophias, 11528 Athens, Greece.
Endocrine Unit, First Department of Propaedeutic and Internal Medicine, Laiko Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
出版信息
Ther Adv Endocrinol Metab. 2022 Nov 14;13:20420188221136755. doi: 10.1177/20420188221136755. eCollection 2022.
Abstract
摘要
相似文献
1
Hyponatraemia in patients on immune checkpoint inhibitors.接受免疫检查点抑制剂治疗患者的低钠血症
Ther Adv Endocrinol Metab. 2022 Nov 14;13:20420188221136755. doi: 10.1177/20420188221136755. eCollection 2022.
2
Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way.免疫疗法治疗内分泌恶性肿瘤：免疫检查点抑制剂引领潮流。
Endocr Relat Cancer. 2017 Dec;24(12):T261-T281. doi: 10.1530/ERC-17-0222. Epub 2017 Sep 11.
3
Hyponatraemia secondary to nivolumab-induced primary adrenal failure.纳武单抗诱导的原发性肾上腺功能衰竭继发低钠血症。
Endocrinol Diabetes Metab Case Rep. 2016;2016. doi: 10.1530/EDM-16-0108. Epub 2016 Nov 1.
4
A Case of Cancer-Associated Hyponatraemia: Primary Adrenal Insufficiency Secondary to Nivolumab.癌症相关性低钠血症病例：纳武利尤单抗引起的原发性肾上腺功能不全。
Endocr Metab Immune Disord Drug Targets. 2022;22(3):363-366. doi: 10.2174/1871530321666210708142815.
5
Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.与免疫检查点抑制剂相关的内分泌相关不良事件：管理的建议算法。
Oncologist. 2020 Apr;25(4):290-300. doi: 10.1634/theoncologist.2018-0470. Epub 2019 Oct 10.
6
A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors.癌症免疫疗法毒性综述：免疫检查点抑制剂。
J Med Toxicol. 2021 Oct;17(4):411-424. doi: 10.1007/s13181-021-00833-8. Epub 2021 Apr 7.
7
Frequency of hyponatraemia and its influence on liver cirrhosis-related complications.低钠血症的发生率及其对肝硬化相关并发症的影响。
J Pak Med Assoc. 2010 Feb;60(2):116-20.
8
Anticancer Medications and Sodium Dysmetabolism.抗癌药物与钠代谢紊乱
Eur Endocrinol. 2020 Oct;16(2):122-130. doi: 10.17925/EE.2020.16.2.122. Epub 2020 Oct 6.
9
The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.免疫检查点抑制剂在结直肠癌治疗中的出现。
Curr Drug Targets. 2021;22(9):1021-1033. doi: 10.2174/1389450122666210204204415.
引用本文的文献
1
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine.免疫检查点抑制剂与肾脏：聚焦个性化医疗的诊断与管理
Cancers (Basel). 2023 Mar 21;15(6):1891. doi: 10.3390/cancers15061891.
本文引用的文献
1
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline.接受免疫检查点抑制治疗患者的内分泌相关不良事件：ESE 临床实践指南。
Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21. doi: 10.1530/EJE-22-0689. Print 2022 Dec 1.
2
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival.接受检查点抑制剂免疫治疗后出现内分泌并发症的肿瘤患者具有更长的无进展生存期和总生存期。
Front Oncol. 2022 Mar 24;12:847917. doi: 10.3389/fonc.2022.847917. eCollection 2022.
3
Adrenal insufficiency.肾上腺功能不全。
Lancet. 2021 Feb 13;397(10274):613-629. doi: 10.1016/S0140-6736(21)00136-7. Epub 2021 Jan 20.
4
How we treat endocrine complications of immune checkpoint inhibitors.免疫检查点抑制剂相关内分泌并发症的治疗方法。
ESMO Open. 2021 Feb;6(1):100011. doi: 10.1016/j.esmoop.2020.100011. Epub 2021 Jan 4.
5
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints.靶向免疫检查点的癌症免疫疗法的内分泌毒性
Endocr Rev. 2019 Feb 1;40(1):17-65. doi: 10.1210/er.2018-00006.
6
Endocrine sequelae of immune checkpoint inhibitors.免疫检查点抑制剂的内分泌后遗症。
Hormones (Athens). 2017 Oct;16(4):341-350. doi: 10.14310/horm.2002.1754.
7
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.不同免疫检查点抑制剂方案应用后内分泌功能障碍的发生率：系统评价和荟萃分析。
JAMA Oncol. 2018 Feb 1;4(2):173-182. doi: 10.1001/jamaoncol.2017.3064.
8
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.免疫疗法毒性管理：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv119-iv142. doi: 10.1093/annonc/mdx225.
9
The blockade of immune checkpoints in cancer immunotherapy.癌症免疫疗法中的免疫检查点阻断。
Nat Rev Cancer. 2012 Mar 22;12(4):252-64. doi: 10.1038/nrc3239.
Zotero 插件